<DOC>
	<DOC>NCT00110487</DOC>
	<brief_summary>The purpose of this investigational study is to determine if a study medication is safe and effective in reducing the symptoms associated with endometriosis; if the study medication reduces the need for pain medication for endometriosis symptoms; and if the study medication improves a participant's ability to carry out daily activities. Qualified participants will receive no cost treatment, which may include study-related examinations, diagnostic procedures including a Pap smear, laboratory testing, and a mammogram (aged 40-45). Qualified participants will also receive study medication at no cost. As a participant, the study volunteer may also experience the satisfaction of knowing she is helping the advancement of women's health care.</brief_summary>
	<brief_title>Study Evaluating ERB-041 in Endometriosis in Reproductive-Age Women</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<criteria>Surgical diagnosis of endometriosis within 5 years Not pregnant and not lactating Willing to use nonhormonal contraception, history of regular menstrual cycles Hysterectomy, surgical treatment for endometriosis within 3 months Certain medications for the treatment of endometriosis Previous history of a malignancy Abnormalities on physical or gyn exams and abnormal lab tests</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2007</verification_date>
	<keyword>Endometriosis</keyword>
</DOC>